Acute effects of a new potassium-sparing diuretic, amiloride hidrochloride (MK-870), alone and in combination with acetazolamide in normal human subjects.
作者信息
Mattar E, Cruz H M, Cruz J
出版信息
AMB Rev Assoc Med Bras. 1969 Sep;15(9):369-76.
PMID:4909931
Abstract
摘要
相似文献
1
Acute effects of a new potassium-sparing diuretic, amiloride hidrochloride (MK-870), alone and in combination with acetazolamide in normal human subjects.
AMB Rev Assoc Med Bras. 1969 Sep;15(9):369-76.
2
The effects of acetazolamide and amiloride on tissue electrolytes, with reference to the teratogenesis of carbonic anhydrase inhibition.乙酰唑胺和阿米洛利对组织电解质的影响，涉及碳酸酐酶抑制的致畸作用。
J Pharmacol Exp Ther. 1972 May;181(2):212-8.
3
[Effect of amiloride (MK-870 or 3-carboguanidino-2,6-diamino-5-chloropyrazine) on urinary electrolyte excretion].
Farmaco Prat. 1971 Oct;26(10):626-31.
4
Magnesium- and potassium-sparing effects of amiloride. Review and recent findings.氨氯吡咪的保镁和保钾作用。综述与最新研究结果
Magnesium. 1984;3(4-6):274-88.
5
Clinical evaluation of amiloride, a potassium-sparing diuretic.氨氯吡咪（一种保钾利尿剂）的临床评估。
Clin Pharmacol Ther. 1969 Jan-Feb;10(1):50-63. doi: 10.1002/cpt196910150.
6
[Clinico-functional evaluation of a new potassium-sparing diuretic: amiloride].
Clin Ter. 1977 Mar 31;80(6):530-6.
7
8
[Treatment of cardiac edema with a new diuretic (combination of amiloride hydrochlorate and hydrochlorothiazide)].
Lille Med. 1974 Feb;19(2):193-98.
9
Clinical studies on amiloride (MK-870) a new potassium-sparing diuretic.新型保钾利尿剂阿米洛利（MK - 870）的临床研究
Indian Heart J. 1969 Jan;21(1):76-85.
10
[Amilorid (MK 870) diuretic saving potassium].[氨氯吡咪（MK 870）利尿保钾]
Rev Lyon Med. 1970 Aug-Sep;19(14):563-6.
Zotero 插件